Symbotic (NASDAQ:SYM – Get Free Report)‘s stock had its “sell” rating reaffirmed by stock analysts at BWS Financial in a research report issued on Wednesday,Benzinga reports. They currently have a $10 ...

Citizens JMP lowered the firm’s price target on Raymond James (RJF) to $175 from $190 and keeps an Outperform rating on the shares. The ...

Fintel reports that on April 2, 2025, Raymond James downgraded their outlook for Synovus Financial - Preferred Stock ...

Raymond James Finl's RJF short percent of float has risen 16.89% since its last report. The company recently reported that it has 6.28 million shares sold short, which is 3.46% of all regular shares ...

As stock markets in the United States sustained the biggest single-day drop since the start of the pandemic, locally based ...

including the appointment of Dr. James Kuffner as CTO in early 2025. These elements, coupled with a follow-on equity offering in early 2024 that raised US$405 million, frame Symbotic's nuanced ...

Symbotic Inc. (SYM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

including the appointment of Dr. James Kuffner as CTO in early 2025. These elements, coupled with a follow-on equity offering in early 2024 that raised US$405 million, frame Symbotic's nuanced journey ...